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Objectives. Female citizens of Sami (the indigenous people of Norway) municipalities in northern Norway
have a low risk of breast cancer. The objective of this study was to describe the attendance rate and outcome
of the Norwegian Breast Cancer Screening Program (NBCSP) in the Sami-speaking municipalities and a
control group.
Study design. A retrospective registry-based study.
Methods. The 8 municipalities included in the administration area of the Sami language law (Sami) were
matched with a control group of 11 municipalities (non-Sami). Population data were accessed from Statistics
Norway. Data regarding invitations and outcome in the NBCSP during the period 2001 2010 was derived
from the Cancer Registry of Norway (CRN). The NBCSP targets women aged 50 69 years. Rates and
percentages were compared using chi-square test with a p-valueB0.05 as statistical significant.
Results. The attendance rate in the NBCSP was 78% in the Sami and 75% in the non-Sami population
(pB0.01). The recall rates were 2.4 and 3.3% in the Sami and non-Sami population, respectively (pB0.01).
The rate of invasive screen detected cancer was not significantly lower in the Sami group (p 0.14). The
percentage of all breast cancers detected in the NBCSP among the Sami (67%) was lower compared with the
non-Sami population (86%, p 0.06).
Conclusion. Despite a lower risk of breast cancer, the Sami attended the NBCSP more frequently than the
control group. The recall and cancer detection rate was lower among the Sami compared with the non-Sami
group.
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S
everal investigators have been concerned about the
uptake of mammographic screening among ethnic
minorities (1 7). The Sami constitute an ethnic
minority in the Norwegian community and live in the
northern regions of Fennoscandia (the northern area of
Norway, Sweden, Finland and Russia’s Kola Peninsula).
The Norwegian government has ratified the Sami as
the indigenous people in Norway (8). The size of the
Sami population has been reckoned to be approximately
75,000 100,000, but estimates vary in accordance with
criteria used such as genetic heritage, mother tongue
and sense of belonging to the Sami. According to
the definitions employed by the Sami parliament, a
Sami is a person who speaks Sami or one of the
parents, grandfathers/grandmothers or great grandfathers/
grandmothers spoke Sami language. In addition self-
assigned Sami ethnicity is included. The majority of the
Sami people in Norway live in the 3 northern counties
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their own language and culture. Traditionally, their lifestyle
diverges from that of the rest of the population in the area,
but occupational expansion traditions are changing.
Research aimed at understanding health issues in the
Sami peoples has been almost lacking, until recently
(9 11). Hassler’s thesis (11) (The health conditions in the
Sami population of Sweden 1961 2002) from the Umea ˚
University, Sweden, has been one of the major works
in this field. In Norway, all inhabitants have equal
rights concerning supply of health care independent of
ethnical group. Norwegian health care authorities have
been concerned about offering the Sami minority and
Norwegians in general the same high quality health care
service (9,10). Despite the fact that the Sami people
are protected by a Sami Act, they have a different native
language and culture that may cause several difficulties
and challenges when assessing the public health care (12).
The services offered by the specialist health care are
generally in Norwegian and the knowledge of Sami
culture and the access to interpreter service is limited.
The challenges experienced by the Sami have often been
summarised as threshold, counter, queue and cultural
challenges. These hindrances may influence on the
attendance rate of the screening programs (5). Further-
more, we have recently documented the Sami municipa-
lities having a significantly reduced risk of breast cancer
(13). On this background, we aimed to clarify the
attendance and screening outcome in the Norwegian
Breast Cancer Screening Program (NBCSP) in the Sami
municipalities and a control group.
Material and methods
Eight municipalities in northern Norway have been
included in the administration area of the Sami language
law. These municipalities were selected as the ‘‘Sami
group’’ in this study. The coastal municipalities of
northern Norway have generally few Sami people and
11 of them were included in the ‘‘non-Sami group.’’ The
11 municipalities in the control group were selected based
on having a coastal and rural location and a population
of less than 4,500 inhabitants (no Sami municipality had
more than 4,100 inhabitants). Furthermore, they were
balanced between counties (Nordland 1, Troms 2 and
Finnmark the other municipalities) similarly as the Sami
group. Municipalities with hospitals were excluded, and
consequently, the control group did not represent the
northern municipalities in general but had similar
characteristics as the Sami municipalities. The location
of the 2 groups is shown in Fig. 1. Their names written in
Sami language (when employed) and Norwegian were
Deatnu/Tana, Unja ´rga/Nesseby, Porsanger/Porsa ´ngu/
Porsanki, Ka ´ra ´sjohka/Karasjok, Guovdageaidnu/
Kautokeino, Ga ´ivuotna/Ka ˚fjord, A ´ sta ´vuona/Lavangen
and Divtasvuona/Tysfjord.
The Cancer Registry of Norway (CRN) is responsible
for the administration and quality control of the NBCSP
that invites all women aged 50 69 years to a 2-view
mammography biennially (14). The program started in
4 counties in 1995/1996 and became nationwide in 2005.
The counties in northern Norway, Troms and Finnmark,
was included in the program in May 2000 and Nordland
in 2001. Stationary screening units were located at the
University hospital of North Norway (UNN) in Tromsø
Fig. 1. The ﬁgure shows the map of northern Norway and the Sami and non-Sami speaking municipalities.
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In addition there were 2 mobile units included in the
screening facilities for the women residing in northern
Norway. In the study period, 2001 2010, a total of 10,122
Sami women and 10,358 non-Sami women were invited
to the NBCSP.
Datawere extracted from the NBCSP-database and the
CRN incidence database, both at the CRN. The annual
number of invitations and subsequent attendances and
recalls (due to mammographic findings, self-reported
symptoms and technical inadequate mammograms) were
given for the period 2001 to 2010. All numbers were given
for each calendar year, in 5-year age groups (50 54 years,
55 59 years, 60 64 years and 65 69 years at screening).
Ductal carcinoma in situ (DCIS) was not included. Breast
cancer incidence data for women who did not attend the
NBCSP were extracted from the CRN incidence database.
There is a delay in reporting and updating of the CRN
incidence database, and cancer data were available only
for the period 2001 2008 for women who did notattend in
the NBCSP. Screen detected and interval breast cancers
were defined as cancer detected in the NBCSP and breast
cancers detected among women who did not attend in the
program as cancers detected outside the program.
Statistical analysis and authorisation
Individual data were analyzed at and by the CRN.
Anonymous and aggregated data were exported to the
first author. Microsoft Excel 2007 version was employed
for the final database, calculations and statistical analysis.
The comparison between study groups with regard to
participation and screening outcome was based on ratios.
The attendance rate of northern Norway was set as 1.0.
Descriptive statistics and the t-test were employed for
the comparison between municipality groups. Signifi-
cance was set to 5%. The t-test was carried out 2-sided.
Collecting information from the screening program in
Norway is covered by the regulations on the collection
and processing of personal health data in the Cancer
Registry (Cancer Registry Regulations) and as the CRN
received only aggregated data, no ethical committee or
Data Inspectorate approval was necessary. Consequently,
no approval from the Regional Committees for Medical
and Health Research Ethics (REK) was necessary.
Similarly, no approval from the Norwegian Social Science
Data Services (NSD) was requested.
Results
Whereas 10,122 and 10,358 invitations were sent to
women in the Sami and non-Sami groups during study
period, a total of 237,294 invitations were sent to women
in northern Norway (Nordland, Troms and Finnmark)
during the study period (Table I). The attendance rate in
northern Norway was 81% (192,237/237,294) in the
period 2001 2010, whereas it was 78% (7,923/10,122) in
the Sami and 75% (7,762/10,358) in the non-Sami group
(pB0.01). The annual ratio (attending/invited) is shown
in Figure 2. The overall recall rates were 2.4% (188/7,923)
and 3.3% (254/7,762), in the Sami and non-Sami popu-
lation, respectively (p 0.01) (Table II). The recall rates
due to mammographic findings were 1.9% (148/7,923)
and 2.7% (206/7,762), respectively (p 0.01). Recall due
to mammographic findings decreased by age in both the
Sami and non-Sami population. Mammographic finding
Fig. 2. The ﬁgure shows the annual ratio (attending/invited) in the 2 study groups compared to the total ﬁgures of northern Norway
(set as 1.0).
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77 and 81% of the recalls among the Sami and non-Sami,
respectively.
The rate of invasive screen detected cancers was lower
in the Sami (0.33%) compared with the non-Sami popu-
lation (0.49%), but the difference did not reach statistical
significant difference (p 0.14). A statistical significant
difference was seen only for the age group 65 69 years
(0.25% vs. 0.83%). Details are shown in Table II.
Discussion
In this study, we have revealed that women aged 50 69
years living in Sami-speaking municipalities took more
frequently part in the NBCSP than women in the control
group. The overall recall rate in the non-Sami group was
1.4 times higher than the Sami group. The percentage of
breast cancers detected as a result of attending the
NBCSP was lower in the Sami group, but the difference
did not reach statistically significant level.
Data quality
We included results only from 2001 to assure complete
years offering screening in the actual population. Data
were extracted by the CRN. The Nordic cancer registries
are known for their high quality (15). In Norway, data on
minorities (such as the Sami people) are not available in
Table I. Number of invitations and attendance rate in the screening program in the Sami and non-Sami group (2001 2010)
Municipality Invited Attended % Ratio
a
Sami group 10,122 7,923 78.3 0.97
Non-Sami group 10,358 7,762 74.9 0.93
Total 20,480 15,685 76.6 0.95
aWhen calculating ratio, northern Norway was set to 1.0.
Table II. Attendance, recall and invasive screen detected cancer rates and positive predictive values (PPV) in the Sami and control
group, 2001 2010
Sami group
50 59 years
n 5,545
60 69 years
n 4,577
Total
n 10,122
n%n%n%
Attending 4,309 77.7 3,614 79.0 7,923 78.3
Recall (total) 116 2.7 74 2.0 190 2.4
Positive mammography 91 2.1 57 1.6 148 1.9
Technical reasons 11 0.3 5 0.1 16 0.2
Self defined lump 14 0.3 12 0.3 26 0.3
Cancer detection
Invasive screen-detected 16 0.3 10 0.3 26 0.3
PPV-1
$ 17.6 17.5 17.6
Non-Sami population
n 5,804 n 4,554 n 10,358
n%n%n%
Attending 4,425 76.2* 3,338 74.9* 7,762 74.9*
Recall (total) 168 3.8 86 2.2 254 3.3
Positive mammography 133 3.0 73 1.8 206 2.7
*
Technical reasons 13 0.3 10 0.3 24 0.3
Self defined lump 21 0.5 3 0.1 24 0.3
Cancer detection
Invasive screen-detected 20 0.5 18 0.3 38 0.5
PPV-1
$ 15.0 24.7 18.4
The Norwegian Breast Cancer Screening Program (NBCSP) database was used.
*Chi square p-valueB0.05 between Sami and Non-Sami populations.
$Positive predictive value-1: invasive breast cancers detected among women recalled due to mammographic findings.
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people based on ethnicity. Those living in the adminis-
tration area of the Sami language law were selected as a
surrogate for the Sami people. The exact percentage of
Sami in each group is not known. However, a Gallup poll
back in October 2000 asked people in Finnmark if they
could speak Sami and included 5 municipalities from the
Sami group and 8 from our control group. The result was
71 and 6%, respectively.
Do the study cohort and the control group differ in any
other way than being mostly Sami and mostly non-Sami,
which possibly could affect the attendance rate? They
differ in geographical setting. Whereas the Sami group is
mainly located in the inland, the control group is only
located in the coastal areas. However, both groups are
living in rural areas.
The County of Nordland entered the national screen-
ing program the 7th of May 2001, about 4 months after
the starting point of our study. However, both study
groups were balanced between counties. In Nordland
County, the municipalities of Tysfjord (Sami group)
and Lødingen (non-Sami group) were matched. They
had during study period a mean of 269 and 305 women
invited per screening round, respectively.
Ethnic minorities and mammography screening
Whereas we expected a lower attendance rate among
the Sami people in the national breast cancer screen-
ing program due to a known reduced risk of cancer
and threshold, counter, queue and cultural challenges
(13,16,17), this was not confirmed in this study. During
the study, we had a meeting with the Sami Medical
Association in Norway and disclosed that the low risk
of breast cancer among the Sami people was well
known among their members. Other investigators have
revealed ethnic minorities having lower participation
rates (1,3 5). A meta-analysis revealed that African-
Americans, Hispanics and Asian/Pacific Islander were
screened less than non-Hispanic white women (3). How-
ever, when controlling for socioeconomic status, ethnic
differences in mammography screening were no longer
significant. An English study (4) pointed especially on
the fact that women in the Muslim population were
less likely to continue to participate in mammography
than those in other South Asian groups. Furthermore,
Chinese American women have been reported experien-
cing low cancer screening rates (5). Masi et al. (5)
reported several screening barriers as knowledge deficits,
foreign language, culture barriers, lack of health insur-
ance, low income and reduced access to transportation.
Furthermore, they mentioned that interventions addres-
sing financial and logistical concerns had increased
mammography in patient populations that were diverse
with respect to race, ethnicity and insurance status.
The use of ‘‘mammography busses’’ in our region and
the national health insurance system in Norway (all
inhabitants are members) may have facilitated logistics
and may have influenced positively on the participa-
tion rate. Furthermore, the Northern Norway Regional
Health Authority trust’s focus on interpreter services
(Sami language), and Sami signposts in several institu-
tions may also have contributed to the attendance rate
among the Sami.
The attendance rate in our study groups were 78 and
75%, respectively. The difference could be due to use of a
private clinic for mammography. Clinics located in Bødø
and Tromsø have offered mammography during study
period. The private alternative might have been a choice
for some more of the non-Sami compared with the Sami
women, but this can only be speculated. Knowing that
rural areas experience lower participation rates (6),
we were satisfied with the attendance rate. The rate is
comparable with the rate achieved in the NBCSP in total
(14). Within Europe, figures have been ranging between
43 and 89% (6,7,18,19). The average in 6 European
countries was 78% (19). The recall rate was 5.4% (range
3.3 17.7%). In this setting, the recall rate in the Sami
group of 2.4% seems low. However, high recall rates
due to false positive results may have different conse-
quences in various ethnic groups. Jafri et al. (1) observed
that, following a false-positive result, black (80%) and
Hispanic women (71%) were significantly less likely to
continue in the screening program than white women
(93%). The Norwegian women pay a fee of about 30 Euro
for the screening examination. However, the fee includes
eventual recall examination and treatment. This might be
of influence for almost 100% compliance in recall exami-
nations in Norway. The Sami population did not differ
from the rest of Norway, and the results were comparable
with previous results for the nationwide program (14).
The percentage of breast cancers detected in the
NBCSP was significantly higher in the non-Sami versus
the Sami group. This was somewhat surprising but may
be due to small numbers. Goldman et al. (2) documented
no difference in mammography sensitivity between facil-
ities serving vulnerable (racial/ethnic minority) and not
vulnerable populations. On the other hand, the difference
in detection rate between the 2 groups should be re-
analysed after several screening rounds and adjusted for
possible risk factors. Taking different risk factors (hor-
monal related factors as age at first birth, number of
births, use of hormonal treatment, in addition to other
life style factors as physical activity, smoking and alcohol
habits) into account, in addition to including the DCIS,
would make us able to make more precise estimates of the
cancer detection.
Conclusion
Women in Sami speaking municipalities have a higher
attendance rate than the non-Sami women, but a lower
Mammographic screening
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in the screening program. The Sami women did also
experience a lower recall rate compared with the non-
Sami women.
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